Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Efficacy and Safety Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled SPROUT Study

被引：0
|
作者：
Fiorillo, Loretta [1 ]
Becker, Emily [2 ]
de Lucas, Raul [3 ]
Belloni-Fortina, Anna [4 ]
Maes, Peter [5 ]
Oberoi, Rajneet K. [5 ]
Paris, Maria [5 ]
Zhang, Wendy [5 ]
Zhang, Zuoshun [5 ]
Arkin, Lisa
机构：
[1] Univ Alberta, Stollery Childrens Hosp, Edmonton, AB, Canada
[2] Driscoll Childrens Hosp, Corpus Christi, TX USA
[3] Hosp Univ La Paz PPDS, Madrid, Spain
[4] Azienda Osped Univ Padova, Padua, Italy
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
42163
引用
下载
收藏
页码：AB122 / AB122
页数：1
相关论文
共 50 条
  • [11] Efficacy and safety of adalimumab versus methotrexate treatment in pediatric patients with severe chronic plaque psoriasis: Results from the 16-Week randomized, double-blind period of a phase 3 study
    Papp, Kim
    Thaci, Diamant
    Marcoux, Danielle
    Weibel, Lisa
    Unnebrink, Kristina
    Williams, David A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S15 - S15
  • [12] Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study
    Bissonnette, R.
    Haydey, R.
    Rosoph, L. A.
    Lynde, C. W.
    Bukhalo, M.
    Fowler, J. F.
    Delorme, I.
    Gagne-Henley, A.
    Gooderham, M.
    Poulin, Y.
    Barber, K.
    Jenkin, P.
    Landells, I.
    Pariser, D. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 403 - 410
  • [13] A phase IV randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of efatizumab in patients with moderate to severe plaque psoriasis involving the scalp
    Kircik, Leon
    Caro, Ivor
    Schlessinger, Joel
    Chen, Yun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB181 - AB181
  • [14] A randomized, double-blind placebo-controlled study of ustekinumab in Japanese patients with moderate to severe plaque psoriasis
    Igarashi, A.
    Kato, T.
    Kato, M.
    Nakagawa, H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 17 - 17
  • [15] The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE)
    Reich, K.
    Gooderham, M.
    Green, L.
    Bewley, A.
    Zhang, Z.
    Khanskaya, I.
    Day, R. M.
    Goncalves, J.
    Shah, K.
    Piguet, V.
    Soung, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (03) : 507 - 517
  • [16] Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study
    Papp, K. A.
    Kaufmann, R.
    Thaci, D.
    Hu, C.
    Sutherland, D.
    Rohane, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (03) : e376 - e383
  • [17] Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double-blind, placebo-controlled study
    Seo, Seong Jun
    Shin, Bong Seok
    Lee, Joo-Heung
    Jeong, Haeyoun
    JOURNAL OF DERMATOLOGY, 2021, 48 (06): : 807 - 817
  • [18] Efficacy and Safety of Baricitinb in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
    Torrelo, A.
    Rewerska, B.
    Paller, Amy
    Prakash, A.
    Zhu, D.
    Pontes, M.
    Wu, Wen-Shuo
    Eichenfield, Lawrence F.
    Boecker, Ulrike
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 99 - 99
  • [19] A randomized, double-blind, placebo-controlled study of ustekinumab in Chinese patients with moderate to severe plaque psoriasis: LOTUS trial results
    Zheng Min
    Zhu Xue-jun
    Song, Michael
    Yaung-Kaung Shen
    Wang Bao-xi
    JOURNAL OF DERMATOLOGY, 2012, 39 : 238 - 239
  • [20] A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
    Papp, K. A.
    Reich, K.
    Paul, C.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Langley, R. G.
    Cather, J.
    Gottlieb, A. B.
    Thaci, D.
    Krueger, J. G.
    Russell, C. B.
    Milmont, C. E.
    Li, J.
    Klekotka, P. A.
    Kricorian, G.
    Nirula, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (02) : 273 - 286
12345